NO20011412L - Methods for down-modulating the immune response to therapeutic proteins - Google Patents

Methods for down-modulating the immune response to therapeutic proteins

Info

Publication number: NO20011412L
Authority: NO; Norway
Prior art keywords: modulating; methods; immune response; therapeutic proteins; proteins
Prior art date: 1998-09-21

Application number

NO20011412A

Other languages

Norwegian (no)

Other versions

NO20011412D0 (en

Inventor

Jiahua Qian

Leon W Hoyer

Mary Collins

Gary S Gray

Original Assignee

Genetics Inst

American Nat Red Cross

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-21

Filing date

2001-03-20

Publication date

2001-05-16

2001-03-20 Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst

2001-03-20 Publication of NO20011412D0 publication Critical patent/NO20011412D0/en

2001-05-16 Publication of NO20011412L publication Critical patent/NO20011412L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20011412A 1998-09-21 2001-03-20 Methods for down-modulating the immune response to therapeutic proteins NO20011412L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15817898A	1998-09-21	1998-09-21
PCT/US1999/021991 WO2000016801A1 (en)	1998-09-21	1999-09-21	Methods of downmodulating the immune response to therapeutic proteins

Publications (2)

Publication Number	Publication Date
NO20011412D0 NO20011412D0 (en)	2001-03-20
NO20011412L true NO20011412L (en)	2001-05-16

Family

ID=22566971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011412A NO20011412L (en)	1998-09-21	2001-03-20	Methods for down-modulating the immune response to therapeutic proteins

Country Status (21)

Country	Link
EP (1)	EP1115423A1 (en)
JP (1)	JP2002526455A (en)
KR (1)	KR20010085830A (en)
CN (1)	CN1331602A (en)
AU (1)	AU761206B2 (en)
BR (1)	BR9913991A (en)
CA (1)	CA2343916A1 (en)
CZ (1)	CZ20011021A3 (en)
EA (1)	EA005236B1 (en)
HK (1)	HK1039059A1 (en)
HU (1)	HUP0103960A3 (en)
IL (1)	IL142069A0 (en)
LT (1)	LT4920B (en)
LV (1)	LV12768B (en)
MX (1)	MXPA01002898A (en)
NO (1)	NO20011412L (en)
NZ (1)	NZ511034A (en)
PL (1)	PL346796A1 (en)
SI (1)	SI20626A (en)
WO (1)	WO2000016801A1 (en)
ZA (1)	ZA200103156B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5397703A (en)	1992-07-09	1995-03-14	Cetus Oncology Corporation	Method for generation of antibodies to cell surface molecules
AU2001261735B2 (en) *	2000-05-19	2006-09-21	The Center For Blood Research, Inc.	Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
EP1636579A4 (en) *	2003-06-10	2011-10-05	Smiths Detection Inc	Sensor arrangement
GB201508024D0 (en) *	2015-05-11	2015-06-24	Haemostatix Ltd	Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5171569A (en)	1985-03-15	1992-12-15	National Research Development Corporation	Factor IX preparations uncontaminated by plasma components or pox virus
US4868112A (en)	1985-04-12	1989-09-19	Genetics Institute, Inc.	Novel procoagulant proteins
US5422260A (en)	1986-05-29	1995-06-06	Genetics Institute, Inc. -Legal Affairs	Human factor VIII:c muteins
US4994371A (en)	1987-08-28	1991-02-19	Davie Earl W	DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (en)	1990-02-05	1994-09-02	Tm Innovation	PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS.
US5661008A (en)	1991-03-15	1997-08-26	Kabi Pharmacia Ab	Recombinant human factor VIII derivatives
DE122007000078I2 (en)	1991-06-27	2011-01-13	Bristol Myers Squibb Co	CTL4A receptor, fusion proteins containing it and their use
US5770197A (en)	1991-06-27	1998-06-23	Bristol-Myers Squibb Company	Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
WO1993009804A1 (en)	1991-11-18	1993-05-27	The Scripps Research Institute	Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5663060A (en)	1992-04-07	1997-09-02	Emory University	Hybrid human/animal factor VIII
US5364771A (en)	1992-04-07	1994-11-15	Emory University	Hybrid human/porcine factor VIII
US5744446A (en)	1992-04-07	1998-04-28	Emory University	Hybrid human/animal factor VIII
US5621039A (en)	1993-06-08	1997-04-15	Hallahan; Terrence W.	Factor IX- polymeric conjugates
AU3161695A (en) *	1994-08-19	1996-03-14	Novo Nordisk A/S	A method of treating a patient with a biologically active compound
CA2200869A1 (en) *	1994-10-19	1996-05-02	Bruce C. Trapnell	Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
US5714583A (en)	1995-06-07	1998-02-03	Genetics Institute, Inc.	Factor IX purification methods
WO1997034633A1 (en) *	1996-03-20	1997-09-25	Bristol-Myers Squibb Company	Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
NZ337073A (en) *	1997-01-10	2001-01-26	Biogen Inc	use of an anti CD40L compound to treat a patient with an autoimmune disease or chronic immune system disorder
CN1651071A (en) *	1997-06-20	2005-08-10	拜奥根Idec马萨诸塞公司	CD154 blockade therapy for therapeutic protein inhibitor syndrome
US8112896B2 (en)	2009-11-06	2012-02-14	Hexagon Metrology Ab	Articulated arm

1999
- 1999-09-21 CA CA002343916A patent/CA2343916A1/en not_active Abandoned
- 1999-09-21 WO PCT/US1999/021991 patent/WO2000016801A1/en not_active Ceased
- 1999-09-21 MX MXPA01002898A patent/MXPA01002898A/en unknown
- 1999-09-21 CZ CZ20011021A patent/CZ20011021A3/en unknown
- 1999-09-21 PL PL99346796A patent/PL346796A1/en not_active Application Discontinuation
- 1999-09-21 KR KR1020017003611A patent/KR20010085830A/en not_active Withdrawn
- 1999-09-21 EA EA200100385A patent/EA005236B1/en not_active IP Right Cessation
- 1999-09-21 HU HU0103960A patent/HUP0103960A3/en unknown
- 1999-09-21 BR BR9913991-0A patent/BR9913991A/en not_active IP Right Cessation
- 1999-09-21 JP JP2000573762A patent/JP2002526455A/en not_active Withdrawn
- 1999-09-21 HK HK02100157.7A patent/HK1039059A1/en unknown
- 1999-09-21 IL IL14206999A patent/IL142069A0/en unknown
- 1999-09-21 CN CN99813510A patent/CN1331602A/en active Pending
- 1999-09-21 AU AU60578/99A patent/AU761206B2/en not_active Ceased
- 1999-09-21 SI SI9920084A patent/SI20626A/en not_active IP Right Cessation
- 1999-09-21 NZ NZ511034A patent/NZ511034A/en unknown
- 1999-09-21 EP EP99969339A patent/EP1115423A1/en not_active Withdrawn
2001
- 2001-03-20 NO NO20011412A patent/NO20011412L/en not_active Application Discontinuation
- 2001-04-18 ZA ZA200103156A patent/ZA200103156B/en unknown
- 2001-04-20 LV LVP-01-62A patent/LV12768B/en unknown
- 2001-04-20 LT LT2001045A patent/LT4920B/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
LT4920B (en)	2002-06-25
WO2000016801A1 (en)	2000-03-30
AU6057899A (en)	2000-04-10
CN1331602A (en)	2002-01-16
PL346796A1 (en)	2002-02-25
EA200100385A1 (en)	2001-10-22
ZA200103156B (en)	2002-07-18
NZ511034A (en)	2004-03-26
JP2002526455A (en)	2002-08-20
EA005236B1 (en)	2004-12-30
NO20011412D0 (en)	2001-03-20
SI20626A (en)	2002-02-28
HUP0103960A2 (en)	2002-02-28
HUP0103960A3 (en)	2003-09-29
LV12768B (en)	2002-06-20
IL142069A0 (en)	2002-03-10
HK1039059A1 (en)	2002-04-12
BR9913991A (en)	2001-07-03
WO2000016801A9 (en)	2000-10-26
LV12768A (en)	2001-12-20
CZ20011021A3 (en)	2001-10-17
MXPA01002898A (en)	2002-06-04
CA2343916A1 (en)	2000-03-30
LT2001045A (en)	2002-01-25
AU761206B2 (en)	2003-05-29
EP1115423A1 (en)	2001-07-18
KR20010085830A (en)	2001-09-07

Publication	Publication Date	Title
NO20001240D0 (en)	2000-03-09	Kay-A immune system protein
NO985464D0 (en)	1998-11-23	Concentrated antibody preparation
NO20004133L (en)	2000-10-18	Antibodies to human CD40
NO983766D0 (en)	1998-08-18	Process for the preparation of N-acetyl-D-glucosamine
NO20004523D0 (en)	2000-09-11	Delivery system to Õ modulate the immune response
EE04390B1 (en)	2004-12-15	Topical preparation for the treatment of dermatological conditions
NO995134L (en)	1999-12-21	Improved Methods for Preparation of Activated Protein C
NO960482L (en)	1996-08-08	The outsole
ID24314A (en)	2000-07-13	PLACE TO PLACE FAST-APPROXIMATELY
FI964285L (en)	1996-10-24	Pharmaceutical preparations based on derivatives belonging to the taxane class
NO995251D0 (en)	1999-10-27	Procedure for administering halotherapy
TR199802394A3 (en)	1999-06-21	Improved process to stabilize proteins.
NO975563L (en)	1999-06-03	Device for holding two objects together
DE69926012D1 (en)	2005-08-04	PHARMACEUTICAL PREPARATIONS
TR199800403A3 (en)	1998-09-21	Method for the preparation of a-Bromo-lactam derivatives.
NO20011412D0 (en)	2001-03-20	Methods for down-modulating the immune response to therapeutic proteins
DE69601919D1 (en)	1999-05-06	PERCOLATOR
NO996432L (en)	2000-02-09	Process for the preparation of 4-substituted-1H-indole-3-glycosamides
NO964376D0 (en)	1996-10-15	The outsole
DK0655503T3 (en)	2002-11-11	Process for the preparation of human serum albumin
NO950950D0 (en)	1995-03-13	Pharmaceutical preparation
DE69906934D1 (en)	2003-05-22	PHARMACEUTICAL PREPARATIONS
FI973826L (en)	1999-03-30	Programs to run
ID17941A (en)	1998-02-12	METHOD OF THE APPLICATION OF MARKA JALAN MAKERS COMPOSITION
NO951679D0 (en)	1995-05-02	Fibronectin-binding protein, as well as its preparation

Legal Events

Date	Code	Title	Description
2006-05-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application